Evidence map›Paper›PMID 27548315›Full record

ArticleNature genetics2016

Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings.

Nicholas A Feasey, James Hadfield, Karen H Keddy, Timothy J Dallman, Jan Jacobs, Xiangyu Deng, Paul Wigley, Lars Barquist, Gemma C Langridge, Theresa Feltwell and 37 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 149 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 5 pooled it
29.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 5 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Prevalence and distribution of non-typhoidalEpidemiology and infection · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. AfricanmBio · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Molecular epidemiology ofAntimicrobial agents and chemotherapy · 2025
    Article
  20. Genomic epidemiology ofMicrobial genomics · 2025
    Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 13 countries.

Nicholas A FeaseyLiverpool School of Tropical Medicine, Liverpool, UK.
James HadfieldWellcome Trust Sanger Institute, Cambridge, UK.
Karen H KeddyCentre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
Timothy J DallmanGastrointestinal Bacteria Reference Unit, Public Health England, Colindale, UK.
Jan JacobsInstitute of Tropical Medicine, Antwerp, Belgium.
Xiangyu DengCenter for Food Safety, Department of Food Science and Technology, University of Georgia.
Paul WigleyInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Lars BarquistInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Gemma C LangridgeWellcome Trust Sanger Institute, Cambridge, UK.
Theresa FeltwellWellcome Trust Sanger Institute, Cambridge, UK.
Simon R HarrisWellcome Trust Sanger Institute, Cambridge, UK.
Alison E MatherWellcome Trust Sanger Institute, Cambridge, UK.
Maria FookesWellcome Trust Sanger Institute, Cambridge, UK.
Martin AslettWellcome Trust Sanger Institute, Cambridge, UK.
Chisomo MsefulaMalawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Samuel KariukiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Calman A MaclennanWellcome Trust Sanger Institute, Cambridge, UK.
Robert S OnsareCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
François-Xavier WeillInstitut Pasteur, Paris, France.
Simon Le HelloInstitut Pasteur, Paris, France.
Anthony M SmithCentre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
Michael McClellandDepartment of Microbiology and Molecular Genetics, University of California, Irvine, CA, USA.
Prerak DesaiDepartment of Microbiology and Molecular Genetics, University of California, Irvine, CA, USA.
Christopher M ParryLiverpool School of Tropical Medicine, Liverpool, UK.
John CheesbroughDepartment of Epidemiology and Population Health, University of Liverpool, Liverpool, UK.
Neil FrenchInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Josefina CamposEnteropathogen Division, Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) Carlos G. Malbran Institute, Buenos Aires, Argentina.
Jose A ChabalgoityInstituto de Higiene, Facultad de Medicina, Universidad de la Republica, Uruguay.
Laura BetancorInstituto de Higiene, Facultad de Medicina, Universidad de la Republica, Uruguay.
Katie L HopkinsAntimicrobial Resistance and Healthcare-Associated Infections Reference Unit, Public Health England, Colindale, UK.
Satheesh NairGastrointestinal Bacteria Reference Unit, Public Health England, Colindale, UK.
Tom J HumphreySwansea Medical School, Swansea University, Swansea, UK.
Octavie LunguyaNational Institute of Biomedical Research, Kinshasa, the Democratic Republic of the Congo.
Tristan A CoganSchool of Veterinary Sciences, University of Bristol, Bristol, UK.
Milagritos D TapiaCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Samba O SowCentre pour le Développement des Vaccins, Bamako, Mali.
Sharon M TennantCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kristin BornsteinCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Lizeth Lacharme-LoraInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Dean B EverettInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Robert A KingsleyWellcome Trust Sanger Institute, Cambridge, UK.
Julian ParkhillWellcome Trust Sanger Institute, Cambridge, UK.
Robert S HeydermanMalawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Gordon DouganWellcome Trust Sanger Institute, Cambridge, UK.
Melita A Gordon *Malawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Nicholas R Thomson *Wellcome Trust Sanger Institute, Cambridge, UK.
Wellcome Sanger Institute · GBUniversity of Liverpool · GBUniversity of Maryland, Baltimore · USPublic Health England · GBInstitut Pasteur · FRKenya Medical Research Institute · KEUniversidad de la República de Uruguay · UYUniversity of California, Irvine · USAdministración Nacional de Laboratorios e Institutos de Salud · ARCenters for Disease Control and Prevention · USCentre Pour le Développement des Vaccins-Mali · MLInstituut voor Tropische Geneeskunde · BEKinshasa General Hospital · CDLiverpool School of Tropical Medicine · GBNational Institute for Communicable DiseasesNorwich Research Park · GBSwansea University · GBUniversity of Bristol · GBUniversity of the Witwatersrand · ZAUniversity of Würzburg · DE

Funding

Integrating geographical and genetic mapping of salmonella disease in an endemicR01AI099525 · NIAID · KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) · PI GUNN, JOHN S, KARIUKI, SAMUEL M · 2013 to 2024
$1.3M
Biotechnology and Biological Sciences Research Council BB/M014088/1NIAID NIH HHS R01 AI099525Wellcome Trust 092152Wellcome Trust 098051Wellcome Trust 100891Wellcome Trust 101113/Z/13/Z
6 · The paper itself

Abstract

An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In high-income settings, it has been responsible for an epidemic of poultry-associated, self-limiting enterocolitis, whereas in sub-Saharan Africa it is a major cause of invasive nontyphoidal Salmonella disease, associated with high case fatality. By whole-genome sequence analysis of 675 isolates of S. Enteritidis from 45 countries, we show the existence of a global epidemic clade and two new clades of S. Enteritidis that are geographically restricted to distinct regions of Africa. The African isolates display genomic degradation, a novel prophage repertoire, and an expanded multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella serotype that displays niche plasticity, with distinct clades that enable it to become a prominent cause of gastroenteritis in association with the industrial production of eggs and of multidrug-resistant, bloodstream-invasive infection in Africa.

Indexed as

Salmonella enteritidisAdaptation, BiologicalAfrica South of the SaharaAnimalsChickensEnterocolitisEpidemicsFemaleGenome, BacterialHumansIncomePlasmidsPoultry DiseasesSalmonella InfectionsSequence Analysis, DNA

Identifiers

PMID27548315
PMCPMC5047355
OpenAlexW2513615729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.